ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2020
Penetrable Nanoplatform for "Cold" Tumor Immune Microenvironment Reeducation.
Open access · goldAbstract read
In one paragraph
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.
0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
4.7field-weighted citation impact, top 4% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
29 citing papers in PubMed, 82 citations in OpenAlex.
- Cancer Management Using Photodynamic Therapy: Fundamentals, Mechanism and Advances.Current pharmaceutical design · 2026Review
- T cell immunotherapy for solid tumors: limitations, progress, and future prospects.Frontiers in immunology · 2026Review
- A smart amphiphilic nanoplatform amplifies ROS-mediated immunogenic cell death to suppress bladder cancer growth and metastasis.Journal of nanobiotechnology · 2025Article
- Strategies to enhance the effects of nanotechnology-mediated photodynamic therapy.Nanomedicine (London, England) · 2025Review
- Sonodynamic therapy-boosted biomimetic nanoplatform targets ferroptosis and CD47 as vulnerabilities for cancer immunotherapy.Journal of nanobiotechnology · 2025Article
- Phototherapy in cancer treatment: strategies and challenges.Signal transduction and targeted therapy · 2025Review
- Advancements in Nano-Delivery Systems for Photodynamic and Photothermal Therapy to Induce Immunogenic Cell Death in Tumor Immunotherapy.International journal of nanomedicine · 2025Review
- Hyaluronic acid-functionalized supramolecular nanophotosensitizers for targeted photoimmunotherapy of triple-negative breast cancer.Journal of nanobiotechnology · 2024Article
- Optogenetically engineered Septin-7 enhances immune cell infiltration of tumor spheroids.Proceedings of the National Academy of Sciences of the United States of America · 2024Article
- Stable triangle: nanomedicine-based synergistic application of phototherapy and immunotherapy for tumor treatment.Journal of nanobiotechnology · 2024Review
- Mechanisms of myeloid-derived suppressor cell-mediated immunosuppression in colorectal cancer and related therapies.World journal of gastrointestinal oncology · 2024Review
- Recent Progress and Prospect of Metal-Organic Framework-Based Nanozymes in Biomedical Application.Nanomaterials (Basel, Switzerland) · 2024Review
- Codelivery of anti-CD47 antibody and chlorin e6 using a dual pH-sensitive nanodrug for photodynamic immunotherapy of osteosarcoma.Oncology research · 2024Article
- Special immune-related adverse events and subsequent photodynamic therapy in tislelizumab treatment for esophageal cancer: a case report.Frontiers in immunology · 2024Article
- Metal-organic framework-based photodynamic combined immunotherapy against the distant development of triple-negative breast cancer.Biomaterials research · 2023Article
- Deep Insight of Design, Mechanism, and Cancer Theranostic Strategy of Nanozymes.Nano-micro letters · 2023Review
- Review
- Hybrid Nanomaterials for Cancer Immunotherapy.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2023Review
- Review
- Insights and Strategies of Melanoma Immunotherapy: Predictive Biomarkers of Response and Resistance and Strategies to Improve Response Rates.International journal of molecular sciences · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors at 1 institution in 2 countries.
Qinjun ChenKey Laboratory of Smart Drug Delivery (Ministry of Education) State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science Institutes of Brain Science Department of Pharmaceutics School of Pharmacy Research Center on Aging and Medicine Fudan University Shanghai 201203 P. R. China.
Yongqing HeKey Laboratory of Smart Drug Delivery (Ministry of Education) State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science Institutes of Brain Science Department of Pharmaceutics School of Pharmacy Research Center on Aging and Medicine Fudan University Shanghai 201203 P. R. China.
Yu WangKey Laboratory of Smart Drug Delivery (Ministry of Education) State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science Institutes of Brain Science Department of Pharmaceutics School of Pharmacy Research Center on Aging and Medicine Fudan University Shanghai 201203 P. R. China.
Chao LiKey Laboratory of Smart Drug Delivery (Ministry of Education) State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science Institutes of Brain Science Department of Pharmaceutics School of Pharmacy Research Center on Aging and Medicine Fudan University Shanghai 201203 P. R. China.
Yujie ZhangKey Laboratory of Smart Drug Delivery (Ministry of Education) State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science Institutes of Brain Science Department of Pharmaceutics School of Pharmacy Research Center on Aging and Medicine Fudan University Shanghai 201203 P. R. China.
Qin GuoKey Laboratory of Smart Drug Delivery (Ministry of Education) State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science Institutes of Brain Science Department of Pharmaceutics School of Pharmacy Research Center on Aging and Medicine Fudan University Shanghai 201203 P. R. China.
Yiwen ZhangKey Laboratory of Smart Drug Delivery (Ministry of Education) State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science Institutes of Brain Science Department of Pharmaceutics School of Pharmacy Research Center on Aging and Medicine Fudan University Shanghai 201203 P. R. China.
Yongchao ChuKey Laboratory of Smart Drug Delivery (Ministry of Education) State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science Institutes of Brain Science Department of Pharmaceutics School of Pharmacy Research Center on Aging and Medicine Fudan University Shanghai 201203 P. R. China.
Peixin LiuKey Laboratory of Smart Drug Delivery (Ministry of Education) State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science Institutes of Brain Science Department of Pharmaceutics School of Pharmacy Research Center on Aging and Medicine Fudan University Shanghai 201203 P. R. China.
Hongyi ChenKey Laboratory of Smart Drug Delivery (Ministry of Education) State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science Institutes of Brain Science Department of Pharmaceutics School of Pharmacy Research Center on Aging and Medicine Fudan University Shanghai 201203 P. R. China.
Zheng ZhouKey Laboratory of Smart Drug Delivery (Ministry of Education) State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science Institutes of Brain Science Department of Pharmaceutics School of Pharmacy Research Center on Aging and Medicine Fudan University Shanghai 201203 P. R. China.
Wenxi ZhouKey Laboratory of Smart Drug Delivery (Ministry of Education) State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science Institutes of Brain Science Department of Pharmaceutics School of Pharmacy Research Center on Aging and Medicine Fudan University Shanghai 201203 P. R. China.
Zhenhao ZhaoKey Laboratory of Smart Drug Delivery (Ministry of Education) State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science Institutes of Brain Science Department of Pharmaceutics School of Pharmacy Research Center on Aging and Medicine Fudan University Shanghai 201203 P. R. China.
Xiaomin LiDepartment of Chemistry and Laboratory of Advanced Materials Fudan University Shanghai 200433 P. R. China.
Tao SunKey Laboratory of Smart Drug Delivery (Ministry of Education) State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science Institutes of Brain Science Department of Pharmaceutics School of Pharmacy Research Center on Aging and Medicine Fudan University Shanghai 201203 P. R. China.
Chen JiangKey Laboratory of Smart Drug Delivery (Ministry of Education) State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science Institutes of Brain Science Department of Pharmaceutics School of Pharmacy Research Center on Aging and Medicine Fudan University Shanghai 201203 P. R. China.ORCID https://orcid.org/0000-0001-5223-2725
Fudan University · CN
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lack of tumor-infiltration lymphocytes (TILs) and resistances by overexpressed immunosuppressive cells (principally, myeloid-derived suppressor cells (MDSCs)) in tumor milieu are two major challenges hindering the effectiveness of immunotherapy for "immune-cold" tumors. In addition, the natural physical barrier existing in solid cancer also limits deeper delivery of drugs. Here, a tumor-targeting and light-responsive-penetrable nanoplatform (Apt/PDGs
Indexed as
antitumor immune responsesimmunogenic cell deathimmunosuppressionmetal–organic frameworkspenetration
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.